biotx.ai logo — Unlocking the full therapeutic potential of the human genome...

biotx.ai

Unlocking the full therapeutic potential of the human genome through algorithms

Founded 2017 Germany Potsdam, Germany 14 employees Convertible Note AI, Biotechnology +1

General Information

Company Name biotx.ai
Founded Year 2017
Location Germany Potsdam, Germany
Employees 14
Industries AI, Biotechnology, Pharmaceutical
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with biotx.ai. To contact biotx.ai, visit biotx.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About biotx.ai

HELLSICHT is a Germany-based biotechnology startup aspiring to unlock the full therapeutic potential of the human genome through algorithms. Their slogan "Unlocking the full therapeutic potential of the human genome through algorithms" reflects their core mission. Since its establishment in 2017, the company has been dedicated to delivering predictive biomarkers as a basis for decision support in precision medicine. Leveraging novel, state-of-the-art machine learning approaches tailored for complex pattern identification in biomedical data, HELLSICHT aims to revolutionize the field of biotechnology and pharmaceuticals. Their recent Convertible Note investment in 05 April 2023 from the Oxford Angel Fund demonstrates their appeal to notable investors. This signifies a great potential and confidence in the company’s vision and business model.

Taxonomy: Precision Medicine, Biomedicine, Predictive Biomarkers, Decision Support, Next-Generation Biomarkers, Diagnostics, Biomarker Discovery, Therapeutic Potential, Human Genome, Algorithms, Biotech, Medical Innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Undisclosed 1
Oxonian Ventures
05 Apr 2023
Seed Round Undisclosed 1
PROTOCOL — by GETTYLAB
08 Nov 2021
Non Equity Assistance Undisclosed 1
Creative Destruction Lab
17 Jun 2019
Seed Round Undisclosed -
02 Dec 2017

biotx.ai Alternatives & Competitors

View All Alternatives
biotx.ai vs
Elucidata
Elucidata United States

The AI Partner Fueling
40+ FDA-Track Drugs

Series A
179 employees
AI, Analytics
biotx.ai vs

Enable precision medicine

6 employees
Biopharma, Biotechnology
biotx.ai vs

Deciphering Biological Complexity to Unleash Many Impactful Medicines

Series A
36 employees
AI, Biotechnology

FAQ About biotx.ai

Unlocking the full therapeutic potential of the human genome through algorithms
biotx.ai was founded in 2017.
biotx.ai is headquartered in Potsdam, Germany.
biotx.ai operates in AI, Biotechnology and Pharmaceutical. Its work centres on Precision Medicine, Biomedicine, Predictive Biomarkers and Decision Support.
biotx.ai has approximately 14 employees.
biotx.ai has completed 4 funding rounds. The latest funding stage is Convertible Note.
Top alternatives and competitors to biotx.ai include Elucidata, LCM Genect, Engine Biosciences, Brainomix, Integra Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
biotx.ai and Elucidata are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for biotx.ai, https://bouncewatch.com/company/hellsicht, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes